VJNeurology is committed to improving our service to you

Share this video  

VJNeurology is committed to improving our service to you

EAN 2020 | Challenges in migraine management

Uwe Reuter • 22 May 2020
EAN 2020
Headache Antibodies Erenumab Rimegepant Topiramate Ubrogepant
Prevention Treatment

Uwe Reuter, MD, PhD, MBA, Charité – University Medicine Berlin, Berlin, Germany, talks on the the biggest challenges remaining in the migraine field. This interview was recorded during an online conference call with The Video Journal of Neurology (VJNeurology).

More from Uwe Reuter

2:30
HER-MES study: erenumab versus topiramate in episodic migraine
Uwe Reuter • 22 May 2020
2:52
Fremanezumab in patients with chronic or episodic migraine
Uwe Reuter • 22 May 2020
1:51
Unmet needs in migraine: addressing inter-ictal burden
Uwe Reuter • 25 Jun 2022
2:33
LIBERTY trial: erenumab in episodic migraine patients with prior preventive treatment failures
Uwe Reuter • 22 May 2020

Related Videos

1:36
New cluster headache treatments are needed to better meet the needs of patients
Rigmor Hojland Jensen • 19 Oct 2023
5:45
New European Academy of Neurology guidelines for cluster headache treatment
Rigmor Hojland Jensen • 19 Oct 2023
3:17
Diagnostic criteria for trigeminal autonomic cephalalgias
Elizabeth Leroux • 18 Oct 2023
2:25
Challenges facing trigeminal autonomic cephalalgia diagnosis
Elizabeth Leroux • 18 Oct 2023
The content of VJNeurology is intended for healthcare professionals